Login
$MRK
$142.47 +$1.86 (1.32%) Live

$MRK 3 SEC Filings

Filed On Filing
01 Sep 2026 Form 3: Gupta Gaurav K, EVP, CIDO

Holds 750 shares of Common Stock

04 May 2026 Form 3: Maraldo David R., EVP & Pres. MMD

Holds 17,819.434 shares of Common Stock

12 Mar 2026 Form 3: Foard Brian, EVP, Specialty, Pharma, & ID

No securities owned

03 Jan 2025 Form 3: Karsanbhai Surendralal Lanca, Director

Holds 1 shares of Common Stock

23 Dec 2024 Form 3: Merck & Co., Inc., 10% owner and 1 other · Personalis Inc

Holds 14,044,943 shares of Common Stock, $0.0001 par value per share

08 Apr 2024 Form 3: Larson Betty D, EVP, Chief HR Officer

No securities owned

17 Jan 2024 Form 3: Merck & Co., Inc., 10% owner and 1 other · Harpoon Therapeutics, Inc.

Holds 0 shares of Common Stock, par value $0.0001

13 Dec 2023 Form 3: Smart Dalton, SVP Fin. - Global Controller

Holds 6.245 shares of Common Stock

26 Jul 2022 Form 3: Romanelli Joseph, President, Human Health Int?l

Holds 25,284.325 shares of Common Stock

08 Jul 2022 Form 3: Guindo Chirfi, Chief Marketing Officer

Holds 2.7 shares of Common Stock

01 Jun 2022 Form 3: Baker Douglas M Jr, Director

Holds 1,000 shares of Common Stock

10 Mar 2022 Form 3: Oosthuizen Johannes Jacobus, SVP, U.S. Market

Holds 13,222.881 shares of Common Stock

10 Mar 2022 Form 3: Garay Arpa, SVP Human Health Global Mktg.

Holds 290 shares of Common Stock

25 Aug 2021 Form 3: Downing Cristal N, Chief Comm. & Public Afrs Ofcr

No securities owned

15 Jul 2021 Form 3: Klobuchar Michael A, EVP - Chief Strategy Officer

Holds 11,064.93 shares of Common Stock

07 May 2021 Form 3: Merck & Co., Inc., 10% owner · Organon & Co

Holds 100 shares of Common Stock

07 Apr 2021 Form 3: Litchfield Caroline, EVP & CFO

Holds 18,242.1241 shares of Common Stock

07 Apr 2021 Form 3: LeCointe-Cephas Lisa, SVP Chief Ethics & Com Officer

Holds 1,219.346 shares of Common Stock

17 Mar 2021 Form 3: Mayo Stephen, Director

Holds 100 shares of Common Stock

04 Mar 2021 Form 3: Merck & Co., Inc., 10% owner and 1 other · Pandion Therapeutics, Inc.

Holds 0 shares of Common Stock, par value $0.001

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support